Why Merit Medical (MMSI) is a Top Value Stock for the Long-Term

Zacks introduces its Style Scores (Value, Growth, Momentum, and VGM) as a complementary tool to its proprietary Zacks Rank, designed to help investors identify high-potential stocks by combining a Zacks Rank #1 or #2 with A or B Style Scores. Merit Medical Systems, Inc. (MMSI) is highlighted as a compelling example, holding a Zacks Rank #2 (Buy) with a VGM Score of A and a Value Style Score of B, supported by a 22.61 forward P/E and recent upward earnings estimate revisions for FY2025, positioning it as a notable value opportunity for long-term investors.

Analysis

Merit Medical Systems (MMSI) presents a compelling case based on a convergence of positive quantitative signals within the Zacks rating framework. The company is assigned a #2 (Buy) rank, supported by a top-tier composite VGM Score of 'A' and a 'B' for Value. This value designation is underpinned by a forward P/E ratio of 22.61, which is presented as an attractive valuation metric. The bullish outlook is further reinforced by positive momentum in analyst sentiment, evidenced by an upward revision to its fiscal 2025 earnings estimate in the last 60 days. This revision has contributed to an increase in the Zacks Consensus Estimate to $3.63 per share for that period. Historically, the company has demonstrated strong execution, delivering an average earnings surprise of +12.9%, which suggests a pattern of exceeding market expectations.

Key Decisions for Investors

• Given the combination of a #2 (Buy) rank, strong A/B style scores, and positive earnings revisions, investors with a value or growth-at-a-reasonable-price (GARP) mandate could consider MMSI a candidate for a long position.
• Investors should monitor the forward P/E of 22.61 as a key valuation benchmark and track future earnings estimate revisions, as these metrics are the primary drivers of the bullish thesis presented.
• The investment case relies on the company's ability to meet or exceed the upwardly revised FY2025 consensus earnings estimate of $3.63 per share, making future earnings reports critical catalysts to watch.